Clinical trial
Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients…
NCT00015691 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00015691 |
|---|---|
| Title | Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Subjects With Hyperinsulinemia and Elevated Waist/Hip Ratio |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy, Hyperinsulinemia |
| Intervention type | Drug |
| Interventions | Metformin hydrochloride, Rosiglitazone maleate |
| Enrollment | 105 |
| Primary completion | Jan 1, 2006 |
| First posted | Aug 31, 2001 |
| Last update posted | Jul 22, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: